Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease

Hypertension
Esther de BeusMASTERPLAN Study Group

Abstract

New options recently became available for treatment of uncontrolled blood pressure. Information on the prevalence of therapy-resistant hypertension (TRH) in patients with chronic kidney disease and its consequences is relevant to balance risks and benefits of potential new therapies. Data of 788 patients with chronic kidney disease came from a multicenter study investigating the effect on outcome of an integrated multifactorial approach delivered by nurse practitioners added to usual care versus usual care alone. Blood pressure was measured at the office and during 30 minutes using an automated oscillometric device. Apparent TRH (aTRH) was defined as a blood pressure ≥130/80 mm Hg despite treatment with ≥3 antihypertensive drugs, including a diuretic or treatment with ≥4 antihypertensive drugs. Participants were followed up for the occurrence of myocardial infarction, stroke or cardiovascular mortality (composite cardiovascular end point) and end-stage renal disease. aTRH was present in 34% (office blood pressure) and in 32% (automated measurements). During 5.3 years of follow-up, 17% of patients with aTRH reached a cardiovascular end point and 27% reached end-stage renal disease. aTRH lead to a 1.5-fold higher risk (95% confid...Continue Reading

References

Apr 3, 2002·Journal of Clinical Epidemiology·Jos Twisk, Wieke de Vente
Apr 29, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN Kidney Disease Outcomes Quality Initiative (K/DOQI)
May 4, 2005·Lancet·Kenneth F Schulz, David A Grimes
Nov 26, 2008·Archives of Internal Medicine·Gil F SallesElizabeth S Muxfeldt
Dec 8, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Paul MuntnerUNKNOWN Chronic Renal Insufficiency Cohort (CRIC) Study Investigators
Nov 2, 2011·Hypertension·Michael E Ernst
Mar 2, 2012·Circulation·Stacie L DaughertyP Michael Ho
Aug 9, 2012·Journal of Hypertension·Martin G Myers
Nov 21, 2012·Nature Reviews. Nephrology·Pantelis A SarafidisGeorge L Bakris
Apr 30, 2013·Journal of the American College of Cardiology·Luca De NicolaRoberto Minutolo
Jul 23, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Rikki M TannerPaul Muntner
Sep 14, 2013·Journal of Hypertension·Eoin O'BrienUNKNOWN European Society of Hypertension Working Group on Blood Pressure Monitoring
Sep 27, 2013·Journal of Human Hypertension·A PersuUNKNOWN European Network COordinating research on Renal Denervation (ENCOReD)
Oct 26, 2013·Journal of the American Society of Nephrology : JASN·Mieke J PeetersJack F M Wetzels
Nov 19, 2013·Journal of Hypertension·Costas TsioufisChristodoulos Stefanadis
Apr 1, 2014·The New England Journal of Medicine·Deepak L BhattUNKNOWN SYMPLICITY HTN-3 Investigators
Jun 3, 2014·Journal of Hypertension·Gianfranco ParatiYuqing Zhang
Jun 24, 2014·Journal of the American Society of Hypertension : JASH·Marguerite R IrvinDavid A Calhoun
Jan 21, 2015·Current Opinion in Pharmacology·Alexandre PersuJan A Staessen

❮ Previous
Next ❯

Citations

Mar 8, 2016·Current Hypertension Reports·Eduardo Pimenta, David A Calhoun
Jul 5, 2016·Frontiers in Physiology·Margreet F Sanders, Peter J Blankestijn
Nov 30, 2016·Clinical Journal of the American Society of Nephrology : CJASN·Branko BraamS Susan Hedayati
Oct 22, 2016·Journal of Clinical Nursing·Haidan XuZhiming Cai
May 17, 2017·Hypertension·Anping Cai, David A Calhoun
Oct 18, 2019·Current Hypertension Reviews·Guillaume LamiraultNantes University Hospital Working Group On Hypertension
Apr 27, 2019·BMC Medicine·Anna SoliniUNKNOWN Renal Insufficiency And Cardiovascular Events (RIACE) Study Group
Oct 1, 2019·Journal of Hypertension·Joris HoltropUNKNOWN SMART Study Group
Mar 7, 2018·Clinical and Experimental Hypertension : CHE·Ying ZhengHongli Lin
Aug 2, 2017·Journal of Hypertension·Nicolette G C van der SandeUNKNOWN SMART study group
May 16, 2018·Frontiers in Physiology·Ionut TudoranceaRadu Iliescu
Sep 4, 2020·Current Hypertension Reports·Panagiotis I Georgianos, Rajiv Agarwal
Jun 11, 2021·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Christian OttRoland E Schmieder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomechanics

Biomechanics examines the generation of internal forces within the body and investigates the effects and control of forces that act on or are produced on tissues. Here are the latest discoveries.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.